Press Releases :: Aethlon Medical, Inc. (AEMD)

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Year

Category

Jun 3, 2024

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

May 15, 2024

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 10, 2024

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Feb 21, 2024

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Feb 14, 2024

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Feb 7, 2024

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

Nov 14, 2023

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

Nov 13, 2023

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer

Nov 6, 2023

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

Oct 10, 2023

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

rss_feed News RSS